Diag-Nose.io (Seed)

Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$2,000,000

Company Info
Founding Year
2020
Traction
Plans to launch a series of clinical studies across the United States in 2025 to further validate its technology.
Founders
Josie Xu
Company Description
Diag-Nose.io is on a mission to eliminate respiratory disease by decoding the airway’s molecular pathways.
Market
Respiratory Care
Location
Menlo Park, California, United States
Coinvestors
Breakthrough Victoria, Radar Ventures, Specialty Physician Associates, Carl Stubbings, Stephen Ho, Richard Lipscombe

Links